Health Catalyst Osake

Health Catalyst ROIC

Sijoitetun pääoman tuotto (ROIC) yhtiöstä Health Catalyst (HCAT) 22.8.2026 päivämäärällä on −44,60 %. Edellisenä vuonna Sijoitetun pääoman tuotto (ROIC) oli −9,30 % — muutos 379,74 % (matalampi).

ROIC

−44,60 %

YoY

379,74%

Viimeksi päivitetty:

Sijoitetun pääoman tuotto (ROIC) yhtiöstä Health Catalyst on 2026 −44,60 % . Sijoitetun pääoman tuotto (ROIC) yhtiöstä Health Catalyst oli 2025 −9,30 % . Se laskee 379,74% matalampi edelliseen vuoteen verrattuna.

Health Catalyst ROIC historia

  • 3 vuotta

  • 10 vuotta

  • 25 vuotta

  • Maksimi

ROIC
Date
ROIC
1.1.2018
17,48 USD
1.1.2019
−24,15 USD
1.1.2020
−25,84 USD
1.1.2021
−21,79 USD
1.1.2022
−21,09 USD
1.1.2023
−19,86 USD
1.1.2024
−9,30 USD
1.1.2025
−44,60 USD
Health Catalyst ROIC historia
VUOSIROICYoY
−44,60 %+379,74%
−9,30 %−53,18%
−19,86 %−5,84%
−21,09 %−3,23%
−21,79 %−15,66%
−25,84 %+7,00%
−24,15 %−238,18%
17,48 %−7,15%
18,82 %
Access this data via the Eulerpool API

Health Catalyst Osakeanalyysi

Mitä Health Catalyst tekee? Health Catalyst Inc is a US-based company specializing in the analysis and management of healthcare data. The company was founded in 2008 by Tom Burton, Steve Barlow, and Dale Sanders in Salt Lake City and has since undergone impressive growth. Health Catalyst's story began with the goal of creating a better healthcare system based on strong data analysis and data-driven decision-making. The founders recognized that the lack of data analysis and consistent data quality in the healthcare industry led to inefficient processes and high costs. The company set out to solve these problems and contribute to better patient care and cost savings. Health Catalyst is divided into several divisions to offer a wide range of solutions for the healthcare industry. These include the areas of data and analytics platform, clinical decision support, population health management, and medical imaging. Health Catalyst's platform offers comprehensive data analysis and process improvements in key areas of business to support high-quality healthcare. In the field of clinical decision support, Health Catalyst provides analysis and tools to make clinical decisions based on data and evidence-based medicine. Health Catalyst's Population Health Management division helps insurers and healthcare providers optimize population health management based on data analysis to achieve better outcomes with reduced costs. In the medical imaging field, Health Catalyst offers solutions to improve workflow integration and quality improvements for medical images and data. Health Catalyst's products include the Analytics platform, a comprehensive platform for managing healthcare data for clinical, financial, and operational decision-making. Health Catalyst's clinical workflow applications support doctors and nurses in making informed decisions and providing optimal care to patients. Health Catalyst's product line for Population Health Management provides tools for risk assessment, population health analysis, and clinical decision support for insurance companies and healthcare providers. Health Catalyst's business model is based on the sale of software products, services, and subscriptions for the use of the healthcare data analytics platform. The company targets a broad customer base, including hospitals, clinics, healthcare providers, insurers, and government agencies. Health Catalyst has become a leading provider of healthcare data analytics and decision support systems. The company has built a global presence by offering solutions to healthcare companies worldwide. Health Catalyst has become a strong innovator in the industry by developing innovative technologies and integrating insights from its extensive data analysis into clinical and operational decisions. Overall, Health Catalyst has a strong vision for the future of healthcare. The company helps overcome the numerous challenges in the healthcare industry by focusing on data analytics and evidence-based decision-making. Health Catalyst's innovative technologies and solutions are expected to contribute to improving healthcare and making it more cost-effective in the coming years. Health Catalyst on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Health Catalyst osakkeesta

Yhtiön Health Catalyst Sijoitetun pääoman tuotto (ROIC) on −44,60 % vuonna 2026.

Sijoitetun pääoman tuotto (ROIC) yhtiöstä Health Catalyst muuttui arvosta −9,30 % arvoon −44,60 %, mikä edustaa 379,74 % muutosta. Arvo on matalampi kuin edellisenä vuonna.

Eurpoolissa voit löytää Sijoitetun pääoman tuotto (ROIC) Health Catalyst:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

ROIC mittaa, kuinka tehokkaasti yritys käyttää sijoitettua pääomaansa voittojen tuottamiseen. ROIC, joka ylittää pääoman kustannukset, luo osakkeenomistajille arvoa.

ROIC = NOPAT / Sijoitettu pääoma

"Hyvä" vaihtelee alan ja yrityksen kehitysvaiheen mukaan. Eulerpoolissa voit verrata Sijoitetun pääoman tuotto (ROIC):n Health Catalyst alan vertaisiin ja alan keskiarvoon arvioidaksesi houkuttelevuuden.

Arvioidakseen Sijoitetun pääoman tuotto (ROIC):n, on olennaista verrata sitä saman alan ja sektorin kilpailijoihin. Eulerpoolissa voit löytää suoria alan vertailuja Sijoitetun pääoman tuotto (ROIC):lle.

Access this data via the Eulerpool API

Kannattavuus — Health Catalyst

Kaikki tunnusluvut — Health Catalyst